Ginseng in traditional herbal prescriptions

Journal of Ginseng Research

Volumn 36, Issue 3, 2012, Pages 225-241

  Park, Ho Jae ^a   Kim, Dong Hyun ^a   Park, Se Jin ^a   Kim, Jong Min ^a   Ryu, Jong Hoon ^a  

^a Kyung Hee University   (South Korea)

Author keywords

Herbal prescription; Historical documents; Modern pharmacological experiments; Panax ginseng; Translational approaches

Indexed keywords

PANAX GINSENG;

EID: 84866329869     PISSN: 12268453     EISSN: None     Source Type: Journal    
DOI: 10.5142/jgr.2012.36.3.225     Document Type: Article

References (172)

1. Yun TK. Brief Introduction of Panax ginseng C.A. Meyer. J Korean Med Sci 2001;16(Suppl):S3-S5.
2. Blumenthal M, Goldberg A, Brinckmann J. Herbal medicine: expanded Commission E monographs. Austin: Integrative Medicine Communications, 2000.
3. Park JW, Ryu B, Yeo I, Jerng UM, Han G, Oh S, Lee J, Kim J. Banha-sasim-tang as an herbal formula for the treatment of functional dyspepsia: a randomized, double-blind, placebo-controlled, two-center trial. Trials 2010;11:83.
4. Mori K, Kondo T, Kamiyama Y, Kano Y, Tominaga K. Preventive effect of Kampo medicine (Hangeshashinto) against irinotecan-induced diarrhea in advanced nonsmall-cell lung cancer. Cancer Chemother Pharmacol 2003;51:403-406.
5. Naito T, Itoh H, Takeyama M. Comparison of the effects of hange-shashin-to and rikkunshi-to on human plasma calcitonin gene-related peptide and substance P levels. Biol Pharm Bull 2003;26:1104-1107.
6. Kase Y, Saitoh K, Makino B, Hashimoto K, Ishige A, Komatsu Y. Relationship between the antidiarrhoeal effects of Hange-Shashin-To and its active components. Phytother Res 1999;13:468-473.
7. Kim HM, Kim YY, Jang HY, Moon SJ, An NH. Action of Sosiho-Tang on systemic and local anaphylaxis by anal administration. Immunopharmacol Immunotoxicol 1999;21:635-643.
8. Deng G, Kurtz RC, Vickers A, Lau N, Yeung KS, Shia J, Cassileth B. A single arm phase II study of a Far-Eastern traditional herbal formulation (sho-sai-ko-to or xiao-chaihu-tang) in chronic hepatitis C patients. J Ethnopharmacol 2011;136:83-87.
9. Lee CH, Wang JD, Chen PC. Risk of liver injury associated with Chinese herbal products containing Radix bupleuri in 639,779 patients with hepatitis B virus infection. PLoS One 2011;6:e16064.
10. Chang JS, Wang KC, Liu HW, Chen MC, Chiang LC, Lin CC. Sho-saiko-to (Xiao-Chai-Hu-Tang) and crude saikosaponins inhibit hepatitis B virus in a stable HBV-producing cell line. Am J Chin Med 2007;35:341-351.
11. Hsu LM, Huang YS, Tsay SH, Chang FY, Lee SD. Acute hepatitis induced by Chinese hepatoprotective herb, xiaochai-hu-tang. J Chin Med Assoc 2006;69:86-88.
12. Itoh S, Marutani K, Nishijima T, Matsuo S, Itabashi M. Liver injuries induced by herbal medicine, syo-saiko-to (xiao-chai-hu-tang). Dig Dis Sci 1995;40:1845-1848.
13. Tajiri H, Kozaiwa K, Ozaki Y, Miki K, Shimuzu K, Okada S. Effect of sho-saiko-to(xiao-chai-hu-tang) on HBeAg clearance in children with chronic hepatitis B virus infection and with sustained liver disease. Am J Chin Med 1991;19:121-129.
14. Hirayama C, Okumura M, Tanikawa K, Yano M, Mizuta M, Ogawa N. A multicenter randomized controlled clinical trial of Shosaiko-to in chronic active hepatitis. Gastroenterol Jpn 1989;24:715-719.
15. Sakaguchi S, Furusawa S, Iizuka Y. Preventive effects of a traditional Chinese medicine (Sho-saiko-to) on septic shock symptoms; approached from heme metabolic disorders in endotoxemia. Biol Pharm Bull 2005;28:165-168.
16. Chen MH, Chen JC, Tsai CC, Wang WC, Chang DC, Lin CC, Hsieh HY. Sho-saiko-to prevents liver fibrosis induced by bile duct ligation in rats. Am J Chin Med 2004;32:195-207.
17. Taira Z, Yabe K, Hamaguchi Y, Hirayama K, Kishimoto M, Ishida S, Ueda Y. Effects of Sho-saiko-to extract and its components, Baicalin, baicalein, glycyrrhizin and glycyrrhetic acid, on pharmacokinetic behavior of salicylamide in carbon tetrachloride intoxicated rats. Food Chem Toxicol 2004;42:803-807.
18. Kusunose M, Qiu B, Cui T, Hamada A, Yoshioka S, Ono M, Miyamura M, Kyotani S, Nishioka Y. Effect of Shosaiko-to extract on hepatic inflammation and fibrosis in dimethylnitrosamine induced liver injury rats. Biol Pharm Bull 2002;25:1417-1421.
19. Fujiwara K, Mochida S, Nagoshi S, Iijima O, Matsuzaki Y, Takeda S, Aburada M. Regulation of hepatic macrophage function by oral administration of xiao-chai-hu-tang (shosaiko-to, TJ-9) in rats. J Ethnopharmacol 1995;46:107-114.
20. Tatsuta M, Iishi H, Baba M, Nakaizumi A, Uehara H. Inhibition by xiao-chai-hu-tang (TJ-9) of development of hepatic foci induced by N-nitrosomorpholine in Sprague-Dawley rats. Jpn J Cancer Res 1991;82:987-992.
21. Yaginuma T, Okamura T, Takeuchi T, Nishii O, Fujimori R. Preventive effect of traditional herbal medicine, shosaikoto, on danazol-induced hepatic damage. Int J Gynaecol Obstet 1989;29:337-341.
22. Amagaya S, Hayakawa M, Ogihara Y, Ohta Y, Fujiwara K, Oka H, Oshio H, Kishi T. Treatment of chronic liver injury in mice by oral administration of xiao-chai-hu-tang. J Ethnopharmacol 1989;25:181-187.
23. Borchers AT, Sakai S, Henderson GL, Harkey MR, Keen CL, Stern JS, Terasawa K, Gershwin ME. Shosaiko-to and other Kampo (Japanese herbal) medicines: a review of their immunomodulatory activities. J Ethnopharmacol 2000;73:1-13.
24. Kaneko M, Kawakita T, Tauchi Y, Saito Y, Suzuki A, Nomoto K. Augmentation of NK activity after oral administration of a traditional Chinese medicine, xiao-chaihu-tang (shosaiko-to). Immunopharmacol Immunotoxicol 1994;16:41-53.
25. Tauchi Y, Yamada A, Kawakita T, Saito Y, Suzuki A, Yoshikai Y, Nomoto K. Enhancement of immunoglobulin A production in Peyer's patches by oral administration of a traditional Chinese medicine, xiao-chai-hutang (Shosaiko-to). Immunopharmacol Immunotoxicol 1993;15:251-272.
26. Matsuura K, Kawakita T, Nakai S, Saito Y, Suzuki A, Nomoto K. Role of B-lymphocytes in the immunopharmacological effects of a traditional Chinese medicine, xiao-chai-hu-tang (shosaiko-to). Int J Immunopharmacol 1993;15:237-243.
27. Kawakita T, Nakai S, Kumazawa Y, Miura O, Yumioka E, Nomoto K. Induction of interferon after administration of a traditional Chinese medicine, xiao-chai-hu-tang (shosaiko-to). Int J Immunopharmacol 1990;12:515-521.
28. Kawakita T, Mitsuyama M, Kumazawa Y, Miura O, Yumioka E, Nomoto K. Contribution of cytokines to time-dependent augmentation of resistance against Listeria monocytogenes after administration of a traditional Chinese medicine, xiao-chai-hu-tang (Japanese name: shosaiko-to). Immunopharmacol Immunotoxicol 1989;11:233-255.
29. Kawakita T, Yamada A, Mitsuyama M, Kumazawa Y, Nomoto K. Protective effect of a traditional Chinese medicine, xiao-chai-hu-tang (Japanese name: shosaiko-to), on Listeria monocytogenes infection in mice. Immunopharmacol Immunotoxicol 1988;10:345-364.
30. Kumazawa Y, Takimoto H, Miura S, Nishimura C, Yamada A, Kawakita T, Nomoto K. Activation of murine peritoneal macrophages by intraperitoneal administration of a traditional Chinese herbal medicine, xiao-chai-hutang (Japanese name: shosaiko-to). Int J Immunopharmacol 1988;10:395-403.
31. Kawakita T, Yamada A, Kumazawa Y, Nomoto K. Functional maturation of immature B cells accumulated in the periphery by an intraperitoneal administration of a traditional Chinese medicine, xiao-chai-hu-tang (Japanese name: shosaiko-to). Immunopharmacol Immunotoxicol 1987;9:299-317.
32. Kawakita T, Yamada A, Mitsuyama M, Kumazawa Y, Nomoto K. Protective effect of a traditional Chinese medicine, xiao-chai-hu-tang (Japanese name: shosaikoto), on Pseudomonas aeruginosa infection in mice. Immunopharmacol Immunotoxicol 1987;9:523-540.
33. Kobayashi T, Song QH, Hong T, Kitamura H, Cyong JC. Preventive effect of Ninjin-to (Ren-Shen-Tang), a Kampo (Japanese traditional) formulation, on spontaneous autoimmune diabetes in non-obese diabetic (NOD) mice. Microbiol Immunol 2000;44:299-305.
34. Oh MS, Huh Y, Bae H, Ahn DK, Park SK. The multi-herbal formula Guibi-tang enhances memory and increases cell proliferation in the rat hippocampus. Neurosci Lett 2005;379:205-208.
35. Tohda C, Naito R, Joyashiki E. Kihi-to, a herbal traditional medicine, improves Abeta(25-35)-induced memory impairment and losses of neurites and synapses. BMC Complement Altern Med 2008;8:49.
36. Kanai S, Taniguchi N, Higashino H. Effect of kami-kihito (jia-wei-gui-pi-tang) for experimental osteopenia. Am J Chin Med 2005;33:41-48.
37. Matsuzaki T, Nomura S, Yamaoka M, Ozaki Y, Yoshimura C, Xie GL, Katsura K, Kagawa H, Ishida T, Fukuhara S. HLA and HPA typing in idiopathic thrombocytopenic purpura patients treated with Kami-kihi-to. Am J Chin Med 1998;26:191-198.
38. Yamaguchi K, Kido H, Kawakatsu T, Fukuroi T, Suzuki M, Yanabu M, Nomura S, Kokawa T, Yasunaga K. Effects of kami-kihi-to (jia-wei-gui-pi-tang) on autoantibodies in patients with chronic immune thrombocytopenic purpura. Am J Chin Med 1993;21:251-255.
39. Hara H, Kataoka S, Anan M, Ueda A, Mutoh T, Tabira T. The therapeutic effects of the herbal medicine, Juzentaiho-to, on amyloid-beta burden in a mouse model of Alzheimer's disease. J Alzheimers Dis 2010;20:427-439.
40. Chino A, Okamoto H, Hirasaki Y, Terasawa K. A case of atopic dermatitis successfully treated with juzentaihoto (Kampo). Altern Ther Health Med 2010;16:62-64.
41. Nakamoto H, Mimura T, Honda N. Orally administrated Juzen-taiho-to/TJ-48 ameliorates erythropoietin (rHuEPO)-resistant anemia in patients on hemodialysis. Hemodial Int 2008;12 Suppl 2:S9-S14.
42. Sho Y, Fujisaki K, Sakashita H, Yamaguchi K, Tahara K, Kubozono O, Ido A, Tsubouchi H. Orally administered Kampo medicine, Juzen-taiho-to, ameliorates anemia during interferon plus ribavirin therapy in patients with chronic hepatitis C. J Gastroenterol 2004;39:1202-1204.
43. Maruyama Y, Hoshida S, Furukawa M, Ito M. Effects of Japanese herbal medicine, Juzen-taiho-to, in otitis-prone children: a preliminary study. Acta Otolaryngol 2009;129:14-18.
44. Tagami K, Niwa K, Lian Z, Gao J, Mori H, Tamaya T. Preventive effect of Juzen-taiho-to on endometrial carcinogenesis in mice is based on Shimotsu-to constituent. Biol Pharm Bull 2004;27:156-161.
45. Lian Z, Niwa K, Gao J, Tagami K, Hashimoto M, Yokoyama Y, Mori H, Tamaya T. Shimotsu-to is the agent in Juzen-taiho-to responsible for the prevention of endometrial carcinogenesis in mice. Cancer Lett 2002;182:19-26.
46. Niwa K, Hashimoto M, Morishita S, Lian Z, Tagami K, Mori H, Tamaya T. Preventive effects of Juzen-taiho-to on N-methyl-N-nitrosourea and estradiol-17beta-induced endometrial carcinogenesis in mice. Carcinogenesis 2001;22:587-591.
47. Sakamoto S, Kudo H, Kuwa K, Suzuki S, Kato T, Kawasaki T, Nakayama T, Kasahara N, Okamoto R. Anticancer effects of a Chinese herbal medicine, juzen-taiho-to, in combination with or without 5-fluorouracil derivative on DNA-synthesizing enzymes in 1,2-dimethylhydrazine induced colonic cancer in rats. Am J Chin Med 1991;19:233-241.
48. Kiyohara H, Matsumoto T, Yamada H. Intestinal immune system modulating polysaccharides in a Japanese herbal (Kampo) medicine, Juzen-Taiho-To. Phytomedicine 2002;9:614-624.
49. Dai Y, Kato M, Takeda K, Kawamoto Y, Akhand AA, Hossain K, Suzuki H, Nakashima I. T-cell-immunitybased inhibitory effects of orally administered herbal medicine juzen-taiho-to on the growth of primarily developed melanocytic tumors in RET-transgenic mice. J Invest Dermatol 2001;117:694-701.
50. Matsumoto T, Yamada H. Orally administered Kampo (Japanese herbal) medicine, "Juzen-Taiho-To" modulates cytokine secretion in gut associated lymphoreticular tissues in mice. Phytomedicine 2000;6:425-430.
51. Kiyohara H, Matsumoto T, Yamada H. Lignin-carbohydrate complexes: intestinal immune system modulating ingredients in kampo (Japanese herbal) medicine, juzentaiho-to. Planta Med 2000;66:20-24.
52. Matsumoto T, Sakurai MH, Kiyohara H, Yamada H. Orally administered decoction of Kampo (Japanese herbal) medicine, "Juzen-Taiho-To" modulates cytokine secretion and induces NKT cells in mouse liver. Immunopharmacology 2000;46:149-161.
53. Iijima K, Sun S, Cyong JC, Jyonouchi H. Juzen-taiho-to, a Japanese herbal medicine, modulates type 1 and type 2 T cell responses in old BALB/c mice. Am J Chin Med 1999;27:191-203.
54. Abe S, Tansho S, Ishibashi H, Inagaki N, Komatsu Y, Yamaguchi H. Protective effect of oral administration of a traditional medicine, Juzen-Taiho-To, and its components on lethal Candida albicans infection in immunosuppressed mice. Immunopharmacol Immunotoxicol 1998;20:421-431.
55. Jeong JS, Ryu BH, Kim JS, Park JW, Choi WC, Yoon SW. Bojungikki-tang for cancer-related fatigue: a pilot randomized clinical trial. Integr Cancer Ther 2010;9:331-338.
56. Shin HY, Shin CH, Shin TY, Lee EJ, Kim HM. Effect of bojungikki-tang on lipopolysaccharide-induced cytokine production from peripheral blood mononuclear cells of chronic fatigue syndrome patients. Immunopharmacol Immunotoxicol 2003;25:491-501.
57. Chen R, Moriya J, Luo X, Yamakawa J, Takahashi T, Sasaki K, Yoshizaki F. Hochu-ekki-to combined with interferon-gamma moderately enhances daily activity of chronic fatigue syndrome mice by increasing NK cell activity, but not neuroprotection. Immunopharmacol Immunotoxicol 2009;31:238-245.
58. Chen R, Moriya J, Yamakawa J, Takahashi T, Li Q, Morimoto S, Iwai K, Sumino H, Yamaguchi N, Kanda T. Brain atrophy in a murine model of chronic fatigue syndrome and beneficial effect of Hochu-ekki-to (TJ-41). Neurochem Res 2008;33:1759-1767.
59. Liu XQ, Wu L, Guo XJ. Effect of Bu-Zhong-Yi-Qi-Tang on deficiency of N-glycan/nitric oxide and islet damage induced by streptozotocin in diabetic rats. World J Gastroenterol 2009;15:1730-1737.
60. Tatsumi K, Shinozuka N, Nakayama K, Sekiya N, Kuriyama T, Fukuchi Y. Hochuekkito improves systemic inflammation and nutritional status in elderly patients with chronic obstructive pulmonary disease. J Am Geriatr Soc 2009;57:169-170.
61. Kimura M, Sasada T, Kanai M, Kawai Y, Yoshida Y, Hayashi E, Iwata S, Takabayashi A. Preventive effect of a traditional herbal medicine, Hochu-ekki-to, on immunosuppression induced by surgical stress. Surg Today 2008;38:316-322.
62. Kuroiwa A, Liou S, Yan H, Eshita A, Naitoh S, Nagayama A. Effect of a traditional Japanese herbal medicine, hochu-ekki-to (Bu-Zhong-Yi-Qi Tang), on immunity in elderly persons. Int Immunopharmacol 2004;4:317-324.
63. Nabeshima S, Murata M, Hamada M, Chong Y, Yamaji K, Hayashi J. Maturation of monocyte-derived dendritic cells by Hochu-ekki-to, a traditional Japanese herbal medicine. Int Immunopharmacol 2004;4:37-45.
64. Furuya Y, Akashi T, Fuse H. Effect of Bu-zhong-yi-qitang on seminal plasma cytokine levels in patients with idiopathic male infertility. Arch Androl 2004;50:11-14.
65. Matsumoto T, Noguchi M, Hayashi O, Makino K, Yamada H. Hochuekkito, a Kampo (traditional Japanese herbal) medicine, enhances mucosal IgA antibody response in mice immunized with antigen-entrapped biodegradable microparticles. Evid Based Complement Alternat Med 2010;7:69-77.
66. Kiyohara H, Nagai T, Munakata K, Nonaka K, Hanawa T, Kim SJ, Yamada H. Stimulating effect of Japanese herbal (kampo) medicine, hochuekkito on upper respiratory mucosal immune system. Evid Based Complement Alternat Med 2006;3:459-467.
67. Kobayashi H, Mizuno N, Kutsuna H, Teramae H, Ueoku S, Onoyama J, Yamanaka K, Fujita N, Ishii M. Hochu-ekkito suppresses development of dermatitis and elevation of serum IgE level in NC/Nga mice. Drugs Exp Clin Res 2003;29:81-84.
68. Nakada T, Watanabe K, Matsumoto T, Santa K, Triizuka K, Hanawa T. Effect of orally administered Hochu-ekki-to, a Japanese herbal medicine, on contact hypersensitivity caused by repeated application of antigen. Int Immunopharmacol 2002;2:901-911.
69. Yamaoka Y, Kawakita T, Nomoto K. Protective effect of a traditional Japanese medicine Hochu-ekki-to (Chinese name: Bu-zhong-yi-qi-tang), on the susceptibility against Listeria monocytogenes in infant mice. Int Immunopharmacol 2001;1:1669-1677.
70. Ishimitsu R, Nishimura H, Kawauchi H, Kawakita T, Yoshikai Y. Dichotomous effect of a traditional Japanese medicine, bu-zhong-yi-qi-tang on allergic asthma in mice. Int Immunopharmacol 2001;1:857-865.
71. Kido T, Mori K, Daikuhara H, Tsuchiya H, Ishige A, Sa-saki H. The protective effect of hochu-ekki-to (TJ-41), a Japanese herbal medicine, against HSV-1 infection in mitomycin C-treated mice. Anticancer Res 2000;20:4109-4113.
72. Harada M, Seta K, Ito O, Tamada K, Li T, Terao H, Takenoyama M, Kimura G, Nomoto K. Concomitant immunity against tumor development is enhanced by the oral administration of a kampo medicine, Hochu-ekki-to (TJ 41: Bu-Zhong-Yi-Qi-Tang). Immunopharmacol Immunotoxicol 1995;17:687-703.
73. Li XY, Takimoto H, Miura S, Yoshikai Y, Matsuzaki G, Nomoto K. Effect of a traditional Chinese medicine, buzhong-yi-qi-tang (Japanese name: Hochu-ekki-to) on the protection against Listeria monocytogenes infection in mice. Immunopharmacol Immunotoxicol 1992;14:383-402.
74. Tsuneoka N, Tajima Y, Kitasato A, Fukuda K, Kitajima T, Adachi T, Mishima T, Kuroki T, Onizuka S, Kanematsu T. Chemopreventative effect of hochu-ekki-to (TJ-41) on chemically induced biliary carcinogenesis in hamsters. J Surg Res 2009;151:22-27.
75. Tajima S, Bando M, Yamasawa H, Ohno S, Moriyama H, Terada M, Takada T, Suzuki E, Gejyo F, Sugiyama Y. Preventive effect of hochu-ekki-to, a Japanese herbal medicine, on bleomycin-induced lung injury in mice. Respirology 2007;12:814-822.
76. Yang SH, Yu CL. Antiinflammatory effects of Bu-zhong yi-qi-tang in patients with perennial allergic rhinitis. J Ethnopharmacol 2008;115:104-109.
77. Shinozuka N, Tatsumi K, Nakamura A, Terada J, Kuriyama T. The traditional herbal medicine Hochuekkito improves systemic inflammation in patients with chronic obstructive pulmonary disease. J Am Geriatr Soc 2007;55:313-314.
78. Tajima S, Bando M, Yamasawa H, Ohno S, Moriyama H, Takada T, Suzuki E, Gejyo F, Sugiyama Y. Preventive effect of Hochu-ekki-to on lipopolysaccharide-induced acute lung injury in BALB/c mice. Lung 2006;184:318-323.
79. Kanehara M, Ogirima T, Tano K, Maenaka T, Ishida T, Zhang B, Li G, Wang X, Guo Y. Effects of Chinese herbal medicine based on hachimi-jio-gan on osteopenia in rats. J Tradit Chin Med 2006;26:72-77.
80. Kobayashi H, Mizuno N, Teramae H, Kutsuna H, Ueoku S, Onoyama J, Yamanaka K, Fujita N, Ishii M. The effects of Hochu-ekki-to in patients with atopic dermatitis resistant to conventional treatment. Int J Tissue React 2004;26:113-117.
81. Ochi T, Kawakita T, Nomoto K. Effects of Hochu-ekkito and Ninjin-youei-to, traditional Japanese medicines, on porcine serum-induced liver fibrosis in rats. Immunopharmacol Immunotoxicol 2004;26:285-298.
82. Yan X, Kita M, Minami M, Yamamoto T, Kuriyama H, Ohno T, Iwakura Y, Imanishi J. Antibacterial effect of Kampo herbal formulation Hochu-ekki-to (Bu-ZhongYi-Qi-Tang) on Helicobacter pylori infection in mice. Microbiol Immunol 2002;46:475-482.
83. Takano F, Ohta Y, Tanaka T, Sasaki K, Kobayashi K, Takahashi T, Yahagi N, Yoshizaki F, Fushiya S, Ohta T. Oral administration of Ren-shen-yang-rong-tang 'Ninjin'yoeito' protects against hematotoxicity and induces immature erythroid progenitor cells in 5-fluorouracilinduced anemia. Evid Based Complement Alternat Med 2009;6:247-256.
84. Egashira N, Yuzurihara M, Hattori N, Sakakibara I, Ishige A. Ninjin-yoei-to (Ren-Shen-Yang-Rong-Tang) and Polygalae radix improves scopolamine-induced impairment of passive avoidance response in mice. Phytomedicine 2003;10:467-473.
85. Nakada T, Watanabe K, Jin GB, Triizuk K, Hanawa T. Effect of ninjin-youei-to on Th1/Th2 type cytokine production in different mouse strains. Am J Chin Med 2002;30:215-223.
86. Nakai S, Kawakita T, Himeno K, Nomoto K. Combined treatments with Ninjin-youei-to (Ren-shen-yang-rongtang) plus a suboptimal dose of prednisolone on autoimmune nephritis in MRL/lpr mice. Int J Immunopharmacol 1998;20:275-284.
87. Nakai S, Kawakita T, Nagasawa H, Himeno K, Nomoto K. Thymus-dependent effects of a traditional Chinese medicine, ren-shen-yang-rong-tang (Japanese name; Ninjinyouei-to), in autoimmune MRI/MP-lpr/lpr mice. Int J Immunopharmacol 1996;18:271-279.
88. Nakai S, Kawakita T, Zhou NN, Matsuura K, Oka M, Nagasawa H, Saito Y, Suzuki A, Himeno K, Nomoto K. Treatment effect of a traditional Chinese medicine, renshen-yang-rong-tang (Japanese name: ninjin-youei-to), on autoimmune MRL/MP-lpr/lpr mice. Int J Immunopharmacol 1993;15:589-596.
89. Harigai E, Nakai S, Kawakita T, Nomoto K. Combined treatment with ren-shen-yang-rong-tang (Japanese name: ninjin-youei-to) plus prednisolone on adjuvant-induced arthritis in Lewis rat. Int J Immunopharmacol 1995;17:411-418.
90. Kono T, Kaneko A, Hira Y, Suzuki T, Chisato N, Ohtake N, Miura N, Watanabe T. Anti-colitis and -adhesion effects of daikenchuto via endogenous adrenomedullin enhancement in Crohn's disease mouse model. J Crohns Colitis 2010;4:161-170.
91. Narita M, Hatano E, Tamaki N, Yamanaka K, Yanagida A, Nagata H, Asechi H, Takada Y, Ikai I, Uemoto S. Daikenchu-to attenuates rat sinusoidal obstruction syndrome by inhibiting the accumulation of neutrophils in the liver. J Gastroenterol Hepatol 2009;24:1051-1057.
92. Kawasaki N, Nakada K, Suzuki Y, Furukawa Y, Hanyu N, Kashiwagi H. Effect of Dai-kenchu-to on gastrointestinal motility and gastric emptying. Int J Surg 2009;7:218-222.
93. Kawasaki N, Nakada K, Nakayoshi T, Furukawa Y, Suzuki Y, Hanyu N, Yanaga K. Effect of Dai-kenchu-to on gastrointestinal motility based on differences in the site and timing of administration. Dig Dis Sci 2007;52:2684-2694.
94. Tokita Y, Yuzurihara M, Sakaguchi M, Satoh K, Kase Y. The pharmacological effects of Daikenchuto, a traditional herbal medicine, on delayed gastrointestinal transit in rat postoperative ileus. J Pharmacol Sci 2007;104:303-310.
95. Tokita Y, Satoh K, Sakaguchi M, Endoh Y, Mori I, Yuzurihara M, Sakakibara I, Kase Y, Takeda S, Sasaki H. The preventive effect of Daikenchuto on postoperative adhesion-induced intestinal obstruction in rats. Inflammo-pharmacology 2007;15:65-66.
96. Fukuda H, Chen C, Mantyh C, Ludwig K, Pappas TN, Takahashi T. The herbal medicine, Dai-Kenchu-to, accelerates delayed gastrointestinal transit after the operation in rats. J Surg Res 2006;131:290-295.
97. Kito Y, Suzuki H. Effects of Dai-kenchu-to on spontaneous activity in the mouse small intestine. J Smooth Muscle Res 2006;42:189-201.
98. Satoh K, Kase Y, Hayakawa T, Murata P, Ishige A, Sasaki H. Dai-kenchu-to enhances accelerated small intestinal movement. Biol Pharm Bull 2001;24:1122-1126.
99. Iwai N, Kume Y, Kimura O, Ono S, Aoi S, Tsuda T. Effects of herbal medicine Dai-Kenchu-to on anorectal function in children with severe constipation. Eur J Pediatr Surg 2007;17:115-118.
100. Sakakibara R, Odaka T, Lui Z, Uchiyama T, Yamaguchi K, Yamaguchi T, Asahina M, Yamamoto T, Ito T, Hattori T. Dietary herb extract dai-kenchu-to ameliorates constipation in parkinsonian patients (Parkinson's disease and multiple system atrophy). Mov Disord 2005;20:261-262.
101. Satoh K, Hashimoto K, Hayakawa T, Ishige A, Kaneko M, Ogihara S, Kurosawa S, Yakabi K, Nakamura T. Mechanism of atropine-resistant contraction induced by Dai-kenchu-to in guinea pig ileum. Jpn J Pharmacol 2001;86:32-37.
102. Satoh K, Hayakawa T, Kase Y, Ishige A, Sasaki H, Nishikawa S, Kurosawa S, Yakabi K, Nakamura T. Mechanisms for contractile effect of Dai-kenchu-to in isolated guinea pig ileum. Dig Dis Sci 2001;46:250-256.
103. Ogasawara T, Morine Y, Ikemoto T, Imura S, Fujii M, Soejima Y, Shimada M. Influence of Dai-kenchu-to (DKT) on human portal blood flow. Hepatogastroenterology 2008;55:574-577.
104. Murata P, Kase Y, Ishige A, Sasaki H, Kurosawa S, Nakamura T. The herbal medicine Dai-kenchu-to and one of its active components [6]-shogaol increase intestinal blood flow in rats. Life Sci 2002;70:2061-2070.
105. Ni Q, Wang J, Li EQ, Zhao AB, Yu B, Wang M, Huang CR. Study on the protective effect of shengmai san (see text) on the myocardium in the type 2 diabetic cardiomyopathy model rat. J Tradit Chin Med 2011;31:209-219.
106. Giridharan VV, Thandavarayan RA, Konishi T. Effect of Shengmai-san on cognitive performance and cerebral oxidative damage in BALB/c mice. J Med Food 2011;14:601-609.
107. Seo TB, Baek K, Kwon KB, Lee SI, Lim JS, Seol IC, Kim YS, Seo YB, Namgung U. Shengmai-san-mediated enhancement of regenerative responses of spinal cord axons after injury in rats. J Pharmacol Sci 2009;110:483-492.
108. Yao HT, Chang YW, Chen CT, Chiang MT, Chang L, Yeh TK. Shengmai San reduces hepatic lipids and lipid peroxidation in rats fed on a high-cholesterol diet. J Ethnopharmacol 2008;116:49-57.
109. Ichikawa H, Wang L, Konishi T. Prevention of cerebral oxidative injury by post-ischemic intravenous administration of Shengmai San. Am J Chin Med 2006;34:591-600.
110. Wang NL, Liou YL, Lin MT, Lin CL, Chang CK. Chinese herbal medicine, Shengmai San, is effective for improving circulatory shock and oxidative damage in the brain during heatstroke. J Pharmacol Sci 2005;97:253-265.
111. Ichikawa H, Wang X, Konishi T. Role of component herbs in antioxidant activity of shengmai san: a traditional Chinese medicine formula preventing cerebral oxidative damage in rat. Am J Chin Med 2003;31:509-521.
112. Ichikawa H, Konishi T. In vitro antioxidant potentials of traditional Chinese medicine, Shengmai San and their relation to in vivo protective effect on cerebral oxidative damage in rats. Biol Pharm Bull 2002;25:898-903.
113. Xuejiang W, Magara T, Konishi T. Prevention and repair of cerebral ischemia-reperfusion injury by Chinese herbal medicine, shengmai san, in rats. Free Radic Res 1999;31:449-455.
114. Yoshie F, Iizuka A, Kubo M, Komatsu Y, Matsumoto A, Itakura H, Takeda H, Matsumiya T, Kondo K. Protective effects of Saiko-ka-ryukotsu-borei-to (Chai-Hu-Jia-LongGu-Mu-Li-Tang) against atherosclerosis in Kurosawa and Kusanagi-hypercholesterolemic (KHC) rabbits. Pharmacol Res 2001;43:481-488.
115. Chen CY, Kuo TL, Sheu SY, Kuo TF. Preventive effects of Chinese herb chai-hu-gui-zhi-tang extract on water immersion restraint stress-induced acute gastric ulceration in rats. J Vet Med Sci 2010;72:679-685.
116. Horie Y, Kajihara M, Mori S, Yamagishi Y, Kimura H, Tamai H, Kato S, Ishii H. Japanese herbal medicine, Saiko-keishi-to, prevents gut ischemia/reperfusioninduced liver injury in rats via nitric oxide. World J Gastroenterol 2004;10:2241-2244.
117. Tatsuta M, Iishi H, Baba M, Narahara H, Yano H, Sakai N. Suppression by Chai-hu-gui-zhi-tang of the development of liver lesions induced by N-nitrosomorpholine in Sprague-Dawley rats. Cancer Lett 2000;152:31-36.
118. Nose M, Tamura M, Ryu N, Mizukami H, Ogihara Y. Sho-saiko-to and Saiko-keisi-to, the traditional Chinese and Japanese herbal medicines, altered hepatic drug-metabolizing enzymes in mice and rats when administered orally for a long time. J Pharm Pharmacol 2003;55:1419-1426.
119. Su SB, Xie MJ, Sawabu N, Motoo Y. Suppressive effect of herbal medicine saikokeishito on acinar cell apoptosis in rat spontaneous chronic pancreatitis. Pancreatology 2007;7:28-36.
120. Su SB, Motoo Y, Xie MJ, Taga H, Sawabu N. Antifibrotic effect of the herbal medicine Saiko-keishi-to (TJ10) on chronic pancreatitis in the WBN/Kob rat. Pancreas 2001;22:8-17.
121. Motoo Y, Su SB, Xie MJ, Taga H, Sawabu N. Effect of herbal medicine Saiko-keishi-to (TJ-10) on rat spontaneous chronic pancreatitis: comparison with other herbal medicines. Int J Pancreatol 2000;27:123-129.
122. Su SB, Motoo Y, Xie MJ, Sakai J, Taga H, Sawabu N. Expression of pancreatitis-associated protein (PAP) in rat spontaneous chronic pancreatitis: effect of herbal medicine Saiko-keishi-to (TJ-10). Pancreas 1999;19:239-247.
123. Sakaguchi M, Goto K, Ichiki H, Hattori N, Iizuka A, Yamamoto M, Takeda S, Ishige A, Aburada M, Yasuda M et al. Effects of Byakko-ka-ninjin-to on salivary secretion and bladder function in rats. J Ethnopharmacol 2005;102:164-169.
124. Aburada T, Ikarashi N, Kagami M, Ichikawa Y, Sugitani M, Maniwa A, Ueda H, Toda T, Ito K, Ochiai W et al. Byakkokaninjinto prevents body water loss by increasing the expression of kidney aquaporin-2 and skin aquaporin-3 in KKAy mice. Phytother Res 2011;25:897-903.
125. Yanagi Y, Yasuda M, Hashida K, Kadokura Y, Yamamoto T, Suzaki H. Mechanism of salivary secretion enhancement by Byakkokaninjinto. Biol Pharm Bull 2008;31:431-435.
126. Kimura M, Kimura I, Chem FJ. Combined potentiating effect of byakko-ka-ninjin-to, its constituents, rhizomes of Anemarrhena asphodeloides, tomosaponin A-III, and calcium on pilocarpine-induced saliva secretion in streptozocin-diabetic mice. Biol Pharm Bull 1996;19:926-931.
127. Tohda C, Sugahara H, Kuraishi Y, Komatsu K. Inhibitory effect of Byakko-ka-ninjin-to on itch in a mouse model of atopic dermatitis. Phytother Res 2000;14:192-194.
128. Tatsumi T, Yamada T, Nagai H, Terasawa K, Tani T, Nunome S, Saiki I. A Kampo formulation: Byakko-kaninjin-to (Bai-Hu-Jia-Ren-Sheng-Tang) inhibits IgEmediated triphasic skin reaction in mice: the role of its constituents in expression of the efficacy. Biol Pharm Bull 2001;24:284-290.
129. Kimura I, Nakashima N, Sugihara Y, Fu-jun C, Kimura M. The antihyperglycaemic blend effect of traditional Chinese medicine byakko-ka-ninjin-to on alloxan and diabetic KK-CA(y) mice. Phytother Res 1999;13:484-488.
130. Fan H, Shen L, Tang Q, Xiong P, Shou Z, Liao Y, Liang L, Chen X. Effect of Wumeiwan on cytokines TNF-alpha, IL-6, IL-8, IL-10 and expression of NF-kappaBp65 in rats with ulcerative colitis. J Huazhong Univ Sci Technol Med Sci 2009;29:650-654.
131. Fan H, Qiu MY, Mei JJ, Shen GX, Liu SL, Chen R. Effects of four regulating-intestine prescriptions on pathology and ultrastructure of colon tissue in rats with ulcerative colitis. World J Gastroenterol 2005;11:4800-4806.
132. Chen FP, Chen FJ, Jong MS, Tsai HL, Wang JR, Hwang SJ. Modern use of Chinese herbal formulae from Shang-Han Lun. Chin Med J (Engl) 2009;122:1889-1894.
133. Xiang YZ, Shang HC, Gao XM, Zhang BL. A comparison of the ancient use of ginseng in traditional Chinese medicine with modern pharmacological experiments and clinical trials. Phytother Res 2008;22:851-858.
134. An X, Zhang AL, Yang AW, Lin L, Wu D, Guo X, Shergis JL, Thien FC, Worsnop CJ, Xue CC. Oral ginseng formulae for stable chronic obstructive pulmonary disease: a systematic review. Respir Med 2011;105:165-176.
135. Zhang Y, Saito H, Nishiyama N. Improving effects of DX-9386, a traditional Chinese medicinal prescription, on thymectomy-induced impairment of learning behaviors in mice. Biol Pharm Bull 1994;17:1199-1205.
136. Choi JH, Kim HM, Song YS, Park SG, Kim JJ, Lee CK. Anti-aging effects Saccharomyces fermented modified Kyungohkgo extract on skin. Korean J Herbol 2007;22:219-225.
137. Scheid V, Bensky D, Ellis A, Barolet R. Chinese herbal medicine: fomulas and strategies. 3rd ed. Seatle: Estland Press, 2009.
138. Panax ginseng. Monograph. Altern Med Rev 2009; 14:172-176.
139. Coon JT, Ernst E. Panax ginseng: a systematic review of adverse effects and drug interactions. Drug Saf 2002;25:323-344.
140. Siow YL, Gong Y, Au-Yeung KK, Woo CW, Choy PC, O K. Emerging issues in traditional Chinese medicine. Can J Physiol Pharmacol 2005;83:321-334.
141. Cho BH. The politics of herbal drugs in Korea. Soc Sci Med 2000;51:505-509.
142. Yu F, Takahashi T, Moriya J, Kawaura K, Yamakawa J, Kusaka K, Itoh T, Morimoto S, Yamaguchi N, Kanda T. Traditional Chinese medicine and Kampo: a review from the distant past for the future. J Int Med Res 2006;34:231-239.
143. Leung KF, Liu FB, Zhao L, Fang JQ, Chan K, Lin LZ. Development and validation of the Chinese Quality of Life Instrument. Health Qual Life Outcomes 2005;3:26.
144. Kishida Y, Nishii T, Inoue T, Nishida S, Arimitsu J, Yoshikawa H, Sugano N. Juzentaihoto (TJ-48), a traditional Japanese herbal medicine, influences hemoglobin recovery during preoperative autologous blood donation and after hip surgery. Int J Clin Pharmacol Ther 2009;47:716-721.
145. Wang XQ, Takahashi T, Zhu SJ, Moriya J, Saegusa S, Yamakawa J, Kusaka K, Itoh T, Kanda T. Effect of Hochu-ekki-to (TJ-41), a Japanese herbal medicine, on daily activity in a murine model of chronic fatigue syndrome. Evid Based Complement Alternat Med 2004;1:203-206.
146. Nagano T, Itoh H, Takeyama M. Effect of Dai-kenchuto on levels of 3 brain-gut peptides (motilin, gastrin and somatostatin) in human plasma. Biol Pharm Bull 1999;22:1131-1133.
147. Nagano T, Itoh H, Takeyama M. Effects of Dai-kenchuto on levels of 5-hydroxytryptamine (serotonin) and vasoactive intestinal peptides in human plasma. Biol Pharm Bull 2000;23:352-353.
148. Itoh T, Yamakawa J, Mai M, Yamaguchi N, Kanda T. The effect of the herbal medicine dai-kenchu-to on postoperative ileus. J Int Med Res 2002;30:428-432.
149. Kawahara H, Yanaga K. The herbal medicine Dai-Kenchu-To directly stimulates colonic motility. Surg Today 2009;39:175-177.
150. Iwabu J, Watanabe J, Hirakura K, Ozaki Y, Hanazaki K. Profiling of the compounds absorbed in human plasma and urine after oral administration of a traditional Japanese (kampo) medicine, daikenchuto. Drug Metab Dispos 2010;38:2040-2048.
151. Sato Y, Katagiri F, Inoue S, Itoh H, Takeyama M. Effects of Ninjin-to on levels of calcitonin gene-related peptide and substance P in human plasma. Biol Pharm Bull 2004;27:2032-2034.
152. Pratico D, Sung S. Lipid peroxidation and oxidative imbalance: early functional events in Alzheimer's disease. J Alzheimers Dis 2004;6:171-175.
153. Parihar MS, Hemnani T. Alzheimer's disease pathogenesis and therapeutic interventions. J Clin Neurosci 2004;11:456-467.
154. Ichikawa H, Konishi T. In vitro antioxidant potentials of traditional Chinese medicine, Shengmai San and their relation to in vivo protective effect on cerebral oxidative damage in rats. Biol Pharm Bull 2002;25:898-903.
155. Wang L, Muxin G, Nishida H, Shirakawa C, Sato S, Konishi T. Psychological stress-induced oxidative stress as a model of sub-healthy condition and the effect of TCM. Evid Based Complement Alternat Med 2007;4:195-202.
156. Nishiyama N, Zhou Y, Takashina K, Saito H. Effects of DX-9386, a traditional Chinese preparation, on passive and active avoidance performances in mice. Biol Pharm Bull 1994;17:1472-1476.
157. Zhang Y, Takashina K, Saito H, Nishiyama N. Anti-aging effect of DX-9386 in senescence accelerated mouse. Biol Pharm Bull 1994;17:866-868.
158. Shin BY, Lee YH, Kim D, Park CS, Lee YW, Cho HJ, Kim DH, Yamamoto Y, Kang DH, Lee S et al. Ameliorating effect of a herbal medicinal prescription, Kyung-Ok-Ko, on scopolamine-induced memory impairment in mice. J Tradit Med 2009;26:35-43.
159. Morimoto Y, Sakata M, Ohno A, Maegawa T, Tajima S. Effects of Byakko-ka-ninjin-to, Bofu-tsusho-san and Gorei-san on blood glucose level, water intake and urine volume in KKAy mice. Yakugaku Zasshi 2002;122:163-168.
160. Jia L, Zhao Y. Current evaluation of the millennium phytomedicine. Ginseng (I): etymology, pharmacognosy, phytochemistry, market and regulations. Curr Med Chem 2009;16:2475-2484.
161. Shibata S. Chemistry and cancer preventing activities of ginseng saponins and some related triterpenoid compounds. J Korean Med Sci 2001;16 Suppl:S28-S37.
162. Paker L, Cadenas E. Herbal and traditional medicine. New York: Marcel Dekker, 2004.
163. Choi KT. Botanical characteristics, pharmacological effects and medicinal components of Korean Panax ginseng C A Meyer. Acta Pharmacol Sin 2008;29:1109-1118.
164. Wood WB, Roh BL, White RP. Cardiovascular actions of Panx ginseng in dogs. Jpn J Pharmacol 1964;14:284-294.
165. Lee KD, Huemer RP. Antitumoral activity of Panax ginseng extracts. Jpn J Pharmacol 1971;21:299-302.
166. Hsu CT. On Panax shinseng Nies, var. Notoginseng Burkill. Jpn J Pharmacol 1956;6:18-28.
167. Park JH, Cha HY, Seo JJ, Hong JT, Han K, Oh KW. Anxiolytic-like effects of ginseng in the elevated plus-maze model: comparison of red ginseng and sun ginseng. Prog Neuropsychopharmacol Biol Psychiatry 2005;29:895-900.
168. Yoo JH, Kwon HC, Kim YJ, Park JH, Yang HO. KG135, enriched with selected ginsenosides, inhibits the proliferation of human prostate cancer cells in culture and inhibits xenograft growth in athymic mice. Cancer Lett 2010;289:99-110.
169. Chen CF, Chiou WF, Zhang JT. Comparison of the pharmacological effects of Panax ginseng and Panax quinquefolium. Acta Pharmacol Sin 2008;29:1103-1108.
170. Hui H, Tang G, Go VL. Hypoglycemic herbs and their action mechanisms. Chin Med 2009;4:11.
171. Chung JW, Kim YJ, Lee SJ, Hahm KB. Korean Red Ginseng: Qualitative and Quantitative Benefits on Helicobacter pylori Infection. J Ginseng Res 2010;34:77-88.
172. Ernst E. Panax ginseng: An Overview of the Clinical Evidence. J Ginseng Res 2010;34:259-263.